Caricamento...

Current paradigms and Evolving concepts in metastatic castration-resistant prostate cancer

Until recently, docetaxel-based therapy represented the only therapy shown to prolong survival in patients with metastatic castration-resistant prostate cancer (mCRPC). The past year and a half has been marked by unprecedented progress in treatments for this disease. Three positive phase III clinica...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pal, Sumanta Kumar, Sartor, Oliver
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3449061/
https://ncbi.nlm.nih.gov/pubmed/21602834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aja.2011.35
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !